Several other RORγt small-molecule modulators have been shown to block Th17 cell differentiation and IL-17A production, as well as demonstrate efficacy in EAE, CIA or imiquimod-induced psoriasis models47, 48, 49, 50, 51, 52, 53. The gene discussed is IL17A; the disease is psoriasis.